Synergy and Mechanism of Leflunomide Plus Fluconazole Against Resistant Candida albicans : An in vitro Study

The global rise in the resistance of to conventional antifungals makes infections harder to treat. The main objective of this study was to investigate the antifungal effects and underlying mechanisms of leflunomide in combination with triazoles against resistant . In this study, the microdilution me...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Infection and drug resistance 2023-01, Vol.16, p.4147-4158
Hauptverfasser: Li, Xiuyun, Zhang, Ning, Zhang, Liuping, Liu, Chang, Zheng, Shicun, Lou, Hongxiang
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The global rise in the resistance of to conventional antifungals makes infections harder to treat. The main objective of this study was to investigate the antifungal effects and underlying mechanisms of leflunomide in combination with triazoles against resistant . In this study, the microdilution method was used to determine the antifungal effects of leflunomide in combination with three triazoles on planktonic cells in vitro. The morphological transition from yeast to hyphae was observed under a microscope. The effects on ROS, metacaspase, efflux pumps, and intracellular calcium concentration were investigated, respectively. Our findings suggested that leflunomide + triazoles showed a synergistic effect against resistant in vitro. Further study concluded that the synergistic mechanisms were resulted from multiple factors, including the inhibited efflux of triazoles, the inhibition of yeast-to-hyphae transition, ROS increasing, metacaspase activation, and [Ca ] disturbance. Leflunomide appears to be a potential enhancer of current antifungal agents for treating candidiasis caused by resistant . This study can also serve as an example to inspire the exploration of new approaches to treating resistant .
ISSN:1178-6973
1178-6973
DOI:10.2147/IDR.S415229